Reply to: Optimising the treatment of HDV infection: efficacy of Bulevirtide, HBV-HDV interactions and the importance of statistical methods

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2024-10-23 DOI:10.1016/j.jhep.2024.10.027

M. Dandri, L. Allweiss, B. Downie, J.J. Wallin

引用次数: 0

Abstract

Section snippets

Author contributions

all authors contributed equally to the reply letter

Financial support

The study was supported by Gilead Sciences and the German Center for Infection Research (TTU Hepatitis 05.822; 05.820).

Declaration of Competing Interest

LA declares no conflict of interest. JJW and BD are employees of Gilead Sciences and holders of Gilead stock. MD: Research collaboration with Gilead Science.

查看原文本刊更多论文

答复优化 HDV 感染的治疗：布来维肽的疗效、HBV-HDV 相互作用以及统计方法的重要性

章节片段作者贡献所有作者对回信的贡献相同财务支持本研究得到了吉利德科学公司和德国感染研究中心（TTU Hepatitis 05.822; 05.820）的支持。JJW 和 BD 是吉利德科学公司的员工和吉利德股票的持有者。MD：与吉利德科学公司有研究合作。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.